Features Partner Sites Information LinkXpress hp
Sign In
Advertise with Us
IBA-Radcal

Download Mobile App




Engineers Develop Method of Detecting Loosened Artificial Hip Implants

By HospiMedica staff writers
Posted on 14 Aug 2007
A more efficient way has been developed of detecting loosened artificial hip implants. More...


Engineers developed a diagnostic test that measures the frequency of sound produced when the femur bone in the leg is vibrated. The new method is much more sensitive than the traditional method of using X-RAYs to detect the loosening of implants, and therefore can diagnose much smaller gaps around the implanted joint.

Around 50,000 people receive total hip replacements in the United Kingdom each year, and many will go on to develop pain from them. It is estimated that within 10 years of having an implant, about a quarter of patients will suffer pain from a loosening of the joint, which are joined to their leg bone by special cement.

Surgeons find it difficult to know whether this is due to an infection, which can be cured by antibiotics, or if the joint has loosened, which means surgery is needed. A reliable diagnostic test is vital to save patients undergoing unnecessary surgery.

Dr. James Cunningham, of the University of Bath's (Bath, UK) department of mechanical engineering, developed the new method of placing a piece of vibrating equipment on to the patient's knee, which vibrates the femur and the hip joint. An ultrasound device is attached to the hip and this picks up sound vibrations from the vibrating joint. If the sound's frequencies are ‘pure'--a regular wave of increasing and decreasing frequencies--then they know the joint is firmly fastened to the bone. If the sound waves are impure and irregular, then the clinicians know that the joint has come loose.

Dr. Cunningham said, "The ultrasound method is better than any other method available now, including the traditional X-ray procedure, which can only pick up a large amount of loosening.” He hopes that the National Health Service (NHS) and other medical organizations will use his findings to develop the device for use in hospitals.


Related Links:
University of Bath

Gold Member
POC Blood Gas Analyzer
Stat Profile Prime Plus
Antipsychotic TDM Assays
Saladax Antipsychotic Assays
Semi‑Automatic Defibrillator
Heart Save AED (ED300)
Radiation Safety Barrier
RayShield Intensi-Barrier
Read the full article by registering today, it's FREE! It's Free!
Register now for FREE to HospiMedica.com and get access to news and events that shape the world of Hospital Medicine.
  • Free digital version edition of HospiMedica International sent by email on regular basis
  • Free print version of HospiMedica International magazine (available only outside USA and Canada).
  • Free and unlimited access to back issues of HospiMedica International in digital format
  • Free HospiMedica International Newsletter sent every week containing the latest news
  • Free breaking news sent via email
  • Free access to Events Calendar
  • Free access to LinkXpress new product services
  • REGISTRATION IS FREE AND EASY!
Click here to Register








Channels

Surgical Techniques

view channel
Image: The fiber in the brain implant is less than half a millimeter thick (Photo courtesy of Peter Aagaard Brixen)

Brain Implant Records Neural Signals and Delivers Precise Medication

Neurological diseases such as epilepsy involve complex interactions across multiple layers of the brain, yet current implants can typically stimulate or record activity from only a single point.... Read more

Patient Care

view channel
Image: The revolutionary automatic IV-Line flushing device set for launch in the EU and US in 2026 (Photo courtesy of Droplet IV)

Revolutionary Automatic IV-Line Flushing Device to Enhance Infusion Care

More than 80% of in-hospital patients receive intravenous (IV) therapy. Every dose of IV medicine delivered in a small volume (<250 mL) infusion bag should be followed by subsequent flushing to ensure... Read more

Business

view channel
Image: Medtronic’s intent to acquire CathWorks follows a 2022 strategic partnership with a co-promotion agreement for the FFRangio System (Photo courtesy of CathWorks)

Medtronic to Acquire Coronary Artery Medtech Company CathWorks

Medtronic plc (Galway, Ireland) has announced that it will exercise its option to acquire CathWorks (Kfar Saba, Israel), a privately held medical device company, which aims to transform how coronary artery... Read more
Copyright © 2000-2026 Globetech Media. All rights reserved.